Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Advanced Heart Failure and Transplant
Is there any hemodynamic benefit in continuing entresto for end-stage heart failure in patients on palliative dobutamine?
Related Questions
How do you think about using contraction alkalosis as a mark of achieving goal diuresis?
What is your approach when a patient has concomitant acute decompensated heart failure and rapid atrial fibrillation?
Do you ever consider sodium supplementation to augment diuresis in patients hospitalized with decompensated heart failure, as discussed in a recent systematic review and meta-analysis?
What are the best techniques to reduce POCUS artifact and increase the diagnostic accuracy of lung ultrasound?
Should an ischemic evaluation be considered in the diagnostic work-up for new-onset diastolic heart failure/HFpEF in patients without clear anginal symptoms?
How do you use IVC caliber and collapsibility to guide decisions about diuresis?
What are your first-line vasopressors of choice for the management of acute severe aortic regurgitation and persistent hypotension/shock?
In patients with moderate calcific mitral stenosis, possible HFpEF and dyspnea on exertion, how would you differentiate the etiology of the symptoms?
What are your preferred echocardiographic parameters and goals for weaning RVAD support?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
